These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
542 related items for PubMed ID: 10209040
1. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, Skorski T. J Exp Med; 1999 Apr 19; 189(8):1229-42. PubMed ID: 10209040 [Abstract] [Full Text] [Related]
2. Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells. Nieborowska-Skorska M, Slupianek A, Skorski T. Oncogene; 2000 Aug 24; 19(36):4117-24. PubMed ID: 10962572 [Abstract] [Full Text] [Related]
3. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. Skorski T, Bellacosa A, Nieborowska-Skorska M, Majewski M, Martinez R, Choi JK, Trotta R, Wlodarski P, Perrotti D, Chan TO, Wasik MA, Tsichlis PN, Calabretta B. EMBO J; 1997 Oct 15; 16(20):6151-61. PubMed ID: 9321394 [Abstract] [Full Text] [Related]
4. The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells. Klejman A, Schreiner SJ, Nieborowska-Skorska M, Slupianek A, Wilson M, Smithgall TE, Skorski T. EMBO J; 2002 Nov 01; 21(21):5766-74. PubMed ID: 12411494 [Abstract] [Full Text] [Related]
8. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma. Shipley JM, Waxman DJ. Mol Pharmacol; 2003 Aug 01; 64(2):355-64. PubMed ID: 12869640 [Abstract] [Full Text] [Related]
9. Down-regulation of interleukin-3/granulocyte-macrophage colony-stimulating factor receptor beta-chain in BCR-ABL(+) human leukemic cells: association with loss of cytokine-mediated Stat-5 activation and protection from apoptosis after BCR-ABL inhibition. Donato NJ, Wu JY, Zhang L, Kantarjian H, Talpaz M. Blood; 2001 May 01; 97(9):2846-53. PubMed ID: 11313280 [Abstract] [Full Text] [Related]
12. CrkL functions as a nuclear adaptor and transcriptional activator in Bcr-Abl-expressing cells. Rhodes J, York RD, Tara D, Tajinda K, Druker BJ. Exp Hematol; 2000 Mar 01; 28(3):305-10. PubMed ID: 10720695 [Abstract] [Full Text] [Related]
13. Bcr/Abl activates transcription of the Bcl-X gene through STAT5. Gesbert F, Griffin JD. Blood; 2000 Sep 15; 96(6):2269-76. PubMed ID: 10979976 [Abstract] [Full Text] [Related]
14. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis. Wilson MB, Schreiner SJ, Choi HJ, Kamens J, Smithgall TE. Oncogene; 2002 Nov 21; 21(53):8075-88. PubMed ID: 12444544 [Abstract] [Full Text] [Related]
18. Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway. Bassermann F, Jahn T, Miething C, Seipel P, Bai RY, Coutinho S, Tybulewicz VL, Peschel C, Duyster J. J Biol Chem; 2002 Apr 05; 277(14):12437-45. PubMed ID: 11790798 [Abstract] [Full Text] [Related]
19. Pim-1 expression is sufficient to induce cytokine independence in murine hematopoietic cells, but is dispensable for BCR-ABL-mediated transformation. Nosaka T, Kitamura T. Exp Hematol; 2002 Jul 05; 30(7):697-702. PubMed ID: 12135666 [Abstract] [Full Text] [Related]
20. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Xie S, Wang Y, Liu J, Sun T, Wilson MB, Smithgall TE, Arlinghaus RB. Oncogene; 2001 Sep 27; 20(43):6188-95. PubMed ID: 11593427 [Abstract] [Full Text] [Related] Page: [Next] [New Search]